This was a retrospective study that used the database of the two ICUs (50 beds) and of the toxicology laboratory of our university hospital to identify the patients
M etformin therapy reduces microvascular complications in type 2 diabetic patients and is increasingly used worldwide. The possible occurrence of a severe lactic acidosis is known as one of its adverse effects. In contrast with the huge number of treated patients, metformin-associated lactic acidosis (MALA) is rare, with an estimated incidence of three per 100,000 metformin-treated pa-tients per year, but is associated with a high mortality rate, averaging 50% (1) . In most cases, MALA occurs in a previously treated type 2 diabetic patient when the contraindications of the drug have been overlooked or more often when a concurrent disease induces an acute renal failure leading to metformin accumulation (2) (3) (4) . In rare cases, MALA is due to a voluntary intoxication and may be observed in nondiabetic healthy children or adults (5) . These cases of voluntary acute metformin intoxications have been rarely reported in the literature and their characteristics and prognosis have not been compared with incidental metformin overdose.
Blood purification by hemodialysis (HD) is considered adequate treatment of MALA because it efficiently removes metformin and lactate by diffusion through the dialyzer membrane. Additionally, a bicarbonate-buffered and high-sodium dialyzate improves the metabolic acidosis and increases blood volume, thus enhancing the renal blood flow. These advantages are of special interest in patients suffering from severe sepsis or diarrheainduced dehydration (6, 7) . Most authors recommend a prolonged duration of HD in these patients, but pharmacokinetic data documenting the removal characteristics in metformin overdose are scarce.
Therefore, we designed this study to document the main characteristics and prognostic factors of patients admitted in the intensive care unit (ICU) for a lifethreatening MALA. We sought to compare patients receiving metformin who developed an incidental overdose with patients admitted for an acute voluntary intoxication. The second aim of the study was to determine the optimal duration of HD according to the characteristics of metformin elimination observed during HD procedures.
Objectives: Metformin-associated lactic acidosis is a rare and serious complication of biguanide treatment. It usually occurs when a precipitating disease induces an acute renal failure and an incidental overdose. Voluntary intoxication is rare. Bicarbonate hemodialysis (HD) is recommended to decrease metformin levels and correct acidosis but its optimal duration has not been determined. This study was designed to document the characteristics and prognostic factors of intentional and incidental metformin overdose and to determine the optimal duration of HD.
Design: Ten years retrospective analysis of patients admitted in intensive care unit for metformin-associated lactic acidosis.
Setting: Two intensive care units (50 beds) in a university hospital.
Measurements and Main Results: Clinical and biological characteristics, organ failures, and sequential metformin levels during HD were recorded. Forty-two patients were included (13 voluntary intoxications and 29 incidental overdoses); 74% of patients were in acute renal failure and needed HD. No death was observed in intentional overdose patients compared with 48.3% mortality in incidental overdose patients. The factors significantly associated with mortality were logistic organ dysfunction system score, pH, plasma lactate, and prothrombin activity. By multivariate analysis, a prothrombin activity <50% was the only independent predictive factor of mortality (relative risk: 59.8; confidence limits: 6.3-568; p < 0.0001). Sequential measurements of metformin levels during HD were consistent with a bicompartmental elimination pattern. A cumulative HD duration of 15 hours was associated with the return of metformin level to the therapeutic normal range.
Conclusions: In our study, the outcome of MALA was uniformly favorable after intentional metformin overdose. The vital prognosis was mainly influenced by the occurrence of multiple organ dysfunctions, the best predictive factor of death being an acute liver dysfunction as assessed by PT activity. Prolonged HD was needed to correct metformin overdose. (Crit Care Med 2009; 37: 2191-2196) KEY WORDS: metformin; lactic acidosis; pharmacokinetics; prognosis; liver dysfunction; prothrombin activity; hemodialysis; intoxication; diabetes mated and manual search of discharge records in the two ICUs and in laboratory databases. Medical records were studied by one author only (A.S.) and patients' personal data were rendered anonymous before statistical analysis. Given that this was a purely retrospective noninterventional study and according to French law, the local ethics committee waived the need for approval of the study.
The definite diagnosis of MALA was considered when the diagnosis had been stated by the clinicians in charge and when the patient's medical records could document at admission a status of hyperlactatemic metabolic acidosis and metformin accumulation assessed by a plasma level higher than 2 mg/L, either due to voluntary intoxication or incidental overdose.
During the whole study period, plasma metformin concentrations were measured by high-performance liquid chromatography (normal therapeutic range: 0.5-2 mg/L).
The following clinical and biological characteristics were studied in all patients:
1. Clinical characteristics: age; gender; preexisting diabetic disease; baseline chronic treatment; occurrence at admission in the ICU of respiratory failure, gastrointestinal disorders (nausea, vomiting, jaundice), neurologic dysfunction (confusion, coma), or cardiovascular dysfunction; need for vasoactive drugs, mechanical ventilation, or extrarenal support; duration of ICU and hospital stay; and mortality in ICU.
Worst biological values recorded in the first
24-hour period in ICU: arterial blood gases (pH, PAO 2 , PaCO 2 , HCO 3 ); arterial lactate; blood urea nitrogen and serum creatinine; glycemia, plasma electrolytes (Na, K, Cl, Ca, and P); plasma anion gap; erythrocyte, leukocyte, and platelet counts; activated partial thromboplastin time; and prothrombin (PT) activity. PT activity was expressed in percent of normal level. It corresponds to the Quick coagulation time, measured in seconds, and in this case was compared with the coagulation time of healthy subjects (usual normal range: 10 -12 seconds, corresponding to 70% to 120% activity). The logistic organ dysfunction system was used to assess organ dysfunction in all patients. This score has been validated to accurately measure the severity of organ dysfunctions and their sequential changes during the ICU stay. The score identifies six different organ dysfunctions: neurologic, cardiovascular, renal, pulmonary, hematologic, and hepatic. The total score may vary from 0 (all variables normal) to 22 (all variables at worst possible values) and may be used to calculate a predicted mortality (8).
Characteristics of the extrarenal support:
The decision to treat patients by HD was made by the physicians in charge in the two ICUs. There was no definite written protocol for this specific situation. Continuous hemo(dia)filtration was not used because metformin elimination from blood and correction of severe hyperlactatemic acidosis are best achieved by a diffusion process across the dialyzer membrane. All patients were hemodialyzed via a venous femoral or jugular blood access on polysulfone or polyacrylonitrile dialyzers and with a lowtemperature (36°C), high-sodium, bicarbonate-buffered dialysate. The ultrafiltration rate and modalities of anticoagulation were adapted by the physicians in charge.
During the whole study period, there were minimal changes in these HD settings.
Both ICUs have used high-permeability dialyzers and bicarbonate buffer since 1985 and there was no significant difference between the two ICUs in the characteristics of extrarenal support, except for anticoagulation. One ICU used standard heparin and the other low-molecular-weight heparin for prevention of blood line clotting.
Statistical Analysis. Data are presented as means Ϯ SD for the entire population and as medians, interquartile range, and extreme values for comparisons between groups. Patients suffering from incidental overdose were com-pared with patients with intentional overdose, and survivors to nonsurvivors, by the Mann-Whitney U test and Fisher's exact test when appropriate. Optimal threshold for numerical parameters were determined by receiver operating characteristics analysis. Explanatory variables of mortality were determined by univariate analysis. Relative risks were computed using logistic regression. Independent risk factors of mortality were assessed by a stepwise logistic regression. Sensitivity, specificity, and relative risk were calculated by standard formulae. Statistical significance was defined as p Ͻ 0.05.
RESULTS

Main Characteristics of the Patients.
Of the patients, 42 were included in the study, representing 0.12% of the 33,320 patients admitted in the same period of time in the two ICUs. Their main clinical and biological characteristics are shown in Table 1 . All patients were chronically treated with metformin for a type 2 diabetes mellitus. Overall at admission, 50% of the patients were in circulatory shock and required a vasoactive support, 45% needed mechanical ventilation, 15% had a severe neurologic dysfunction, and 74% were in acute renal failure. Thirteen patients were admitted for a suicide attempt with metformin voluntary intoxication and constituted the intentional overdose group (group I). In the 29 other patients, the reasons for admission to ICU were always a circulatory or a respiratory failure with multiorgan dysfunction (incidental overdose group: group II). Main results of the comparison between both groups are shown in Table 2 . In the entire population, a significant correlation was found between metformin levels and pH (r ϭ .764; p Ͻ 0.0001; Fig. 1A ).
Prognostic Factors. At admission, the mean probability of mortality based on the logistic organ dysfunction system score was 39%. Fourteen of the 42 patients (33%) died in the hospital. The overall mortality rate in group II was 48.3%, whereas 100% of patients in group I recovered without sequelae. The main results of univariate comparison between survivors and nonsurvivors are shown in Table 3 . By univariate analysis, significant differences were found between survivors and nonsurvivors as for age (p ϭ 0.016), arterial pH (p ϭ 0.005), arterial lactate level (p ϭ 0.01), PT activity (p Ͻ 0.0001), need for mechanical ventilation (p ϭ 0.0007), and need for vasoactive support (p ϭ 0.003). There was no relevant difference in mean metformin levels between survivors and non- survivors (23.8 vs. 34 mg/L, respectively). We performed a multivariate analysis to determine the factors independently associated with mortality, with the following variables entered in the multivariate model: age, arterial blood lactate, pH, logistic organ dysfunction system score, and PT activity. The relative risks of death for significant variables are shown in Table 4 . The only variable significantly associated with mortality in this multivariate model was the level of PT activity at admission (p Ͻ 0.0001). By box plot analysis and determination of receiver operating characteristics curve, a PT activity Ͻ50% was associated with subsequent death with a sensitivity of 92%, a specificity of 82%, a relative risk of 59.8 (confidence limits: 6.3-568), and an area under the receiver operating characteristics curve of 0.935. There was a significant correlation between PT activity and the following parameters: metformin plasma levels (r ϭ .419; p ϭ 0.0057), arterial pH (r ϭ .621; p Ͻ 0.0001), and arterial blood lactate (r ϭ .568; p Ͻ 0.0001; Fig. 1B ).
The analysis of patients' records showed that the PT activity was Ͻ50% in 17 patients and Ͻ70% in 23 of 42 patients, one of them only being admitted for voluntary intoxication. Eleven of these patients were admitted to the emergency ward for diagnosis and treatment of gastrointestinal disorders, nine were comatose, and 12 had a cardiorespiratory distress. At admission, arterial pH was Ͻ7.0 in 15 patients; 11 presented with hyperbilirubinemia and hypoalbuminemia, and four with liver cytolysis. Five patients only were thrombocytopenic, whereas 22 were in acute renal failure and 20 needed a vasoactive support. Overall, a clear explanation of the decreased PT activity was found in 13 patients: Two patients had a previously documented liver cirrhosis, two a chronic severe alcohol intoxication, three for which they received coumarin chronic supraventricular arrhythmia, and six had a severe sepsis or circulatory shock at admission, which could have induced a liver ischemia or disseminated intravascular coagulation. In ten pa-tients, the decreased PT activity could not be explained, except by the metformin intoxication itself. Box plot of PT activity in survivors and nonsurvivors is depicted in Figure 2 .
Modalities and Results of Extrarenal Support. Of all patients, 31 were treated by HD, always initiated in the first 12 hours after admission in the ICU. Mean values of HD settings were as follows: blood flow, 216 Ϯ 42 mL/min; dialysate flow, 500 mL/ min; mean duration, 13 Ϯ 9 hours (range: 2-40). Four patients were hemodialyzed in group I (30%) vs. 27 patients in group II (93%). The cumulative duration of HD in this latter group was significantly different between survivors (n ϭ 13) and nonsurvivors (n ϭ 14) with a mean value of 17.4 vs. 10.4 hours, respectively (p ϭ 0.048). Sequential measurements of plasma metformin levels during HD showed that in 85% of patients, a cumulative HD duration of 15 hours was associated with the return of metformin level to normal therapeutic values (Fig. 3) .
The superposition of the plasma concentration-time curves (Fig. 4) depicted an exponential elimination profile of blood metformin and resulted in the following equation The rate of metformin elimination from the blood compartment could be estimated to be 11.58%/hr of HD during the first 2 hours of the procedure. Subsequently, metformin levels reached a plateau consistent with a gradient of metformin concentration between the intracellular space and blood. After 15 hours of HD, the amount of metformin elimination was 1.57%/hr.
DISCUSSION
The association of severe lactic acidosis with biguanide treatment has been recognized for over 45 years and the cur-rent contraindications to metformin administration have been defined for prevention of this adverse event. Renal dysfunction, chronic cardiac or respiratory failure, impaired liver function, sepsis, and severe dehydration are considered to increase the risk for metformin accumulation. In most cases, the patients who develop a severe lactic acidosis under metformin treatment suffer from acute renal failure or severe sepsis. In this situation of MALA, it remains difficult to establish the exclusive role of metformin accumulation (2, 9 -11) . Thus, given the profound benefit of the drug and the weak evidence of such a direct causative link, some authors recently suggested less ambiguous contraindications and revisited guidelines for withdrawing metformin, focusing on the metformin renal clearance and the associated diseases leading to tissue hypoxia (3). A completely different situation is represented by metformin voluntary intoxication, usually as a suicide attempt, occurring in diabetic or healthy subjects who develop a lactic acidosis directly induced by the drug (4, 6, 10, 11) . In our study, many significant differences were observed between patients admitted for voluntary intoxication and patients admitted for incidental metformin accumulation and none of the patients died in the intentional overdose group. In the sole previously published comparable series of metformin intoxications (13 patients), one fatality occurred in a patient who coingested a sulfonylurea and presented with circulatory shock (11) . A case series of 55 accidental intoxications in healthy children has shown that by itself, metformin was not associated with severe lactic acidosis (5) . Thus, the overall prognosis of metformin-induced lactic acidosis after voluntary intoxication or in diabetic patients without severe morbidities appears good. Such a favorable outcome is conditioned by the admission and management of these patients in the ICU, because about 30% will develop severe acidosis and require HD.
The discrepant outcomes of these two groups suggest that the mechanisms of disease may differ. Metformin exerts its antihyperglycemic effect primarily by inhibiting hepatic gluconeogenesis and by increasing the action of insulin in certain target organs, namely muscle and fat. In experimental models, it increases the splanchnic lactate production by stimulating anaerobic glucose metabolism. In case of overdose, metformin binds to mitochondrial membranes, thereby inhibiting the electron transport system. This inhibition induces a shift toward anaerobic intracellular metabolism, which yields large quantities of lactate, coupled with an impaired utilization due to suppression of hepatic gluconeogenesis (12) . Conversely, experimental studies in the LODS, logistic organ dysfunction system. The prothrombin activity was the only independent risk factor of mortality by stepwise analysis.
septic murine model have shown that even at doses mimicking accumulation, metformin did not increase mortality and may even be protective (13) . Furthermore, in the clinical setting, lactate and metformin levels do not correlate with the mortality rate, suggesting that additional factors play a substantial role in the outcome (4, 11) . Our study gives confirmation that blood lactate and metformin concentration do not correlate with mortality and that death is primarily linked to the underlying health status and to the severity of the acute multivisceral dysfunction, as assessed by the logistic organ dysfunction system score.
One major additional finding of our study is that the PT activity measured at admission in the ICU was the only independent risk factor of mortality. Such a decreased PT activity could be linked to a severe underlying chronic liver failure that should have represented a strict contraindication to treatment. This was the case in the retrospective study of 47 patients reported by Stades et al (4) , in which sepsis, circulatory shock, and endstage hepatic failure were the main identifiable prognostic factors. In their study, previously known liver cirrhosis was associated with mortality with an odds ratio of 41. Contrasting with these data, in our study, the analysis of the nonsurviving patients showed that most of them did not suffer from a chronic liver disease, but at admission had clinical and biological features consistent with a severe acute liver dysfunction. Additionally, there was a strong correlation between the PT activity and the lactate or metformin concentrations. We suggest from these findings that the association of an acute liver dysfunction with metformin overdose may induce a major impairment in the aerobic glycolysis and lactate metabolization by liver cells. In several patients, we did not find any explanation of the decreased PT activity, except by a potential direct metformin effect on hepatocyte function. This hypothesis is supported by recent studies showing that high concentrations of metformin could directly induce a liver dysfunction with mitochondrial impairment and thus may explain some cases of acute liver injury observed in metformin-treated patients (14, 15) . Unfortunately, in our study, patients with severe liver failure frequently received fresh-frozen plasma after admission that obscured the analysis of PT activity and we were unable to study the spontaneous sequential changes in their liver function.
The current therapeutic approach of MALA associates correction of acidosis, acceleration of lactate metabolism, elimination of metformin, and management of any concurrent disease. The use of intravenous bicarbonate is known to worsen intracellular acidosis and hyperlactatemia and to induce sodium overload (16, 17) . Metformin has a molecular weight of 165 Da, is highly water soluble, and had a very large volume of distribution (range: 63-276 L). Renal clearance may exceed 450 mL/min in healthy subjects and metformin blood levels are known to correlate with serum creatinine concentration (18) . Thus, significant amounts of the molecule are available for dialysis in the overdose situation and HD is recommended to enhance metformin elimination as well as to treat metabolic acidosis (19, 20) . A rebound in metformin plasma levels due to cellular accumulation has been described in some patients (20) and the measurement of metformin levels in erythrocytes has been proposed as a better indicator of drug accumulation (21, 22) . Unfortunately, this measurement was not available in our patients. In our study, the concentrationtime curves of metformin plasma levels showed a biphasic pattern of elimination consistent with a two-compartment model. These results are highly consistent with the pharmacokinetic analysis performed in healthy subjects that indicated a two-compartment distribution of the drug with a half-life of ϳ2 hours in the central compartment and 16 hours in the deep compartment (18) . This value is comparable with the minimal 15 hours duration of HD associated with the return of metformin levels to therapeutic range. Our study has clear limitations mainly due to its retrospective design and to the relatively low number of studied patients. To the best of our knowledge, however, this is the only study that could compare in the same setting patients admitted for metformin voluntary intoxication with patients admitted for incidental metformin overdose. Our pharmacokinetic results and the proposed HD duration should be interpreted with caution because they may not apply to other HD settings.
We conclude from our study that the prognosis of metformin-induced lactic acidosis due to a voluntary intoxication carries a low risk of death, provided that a symptomatic management is realized in the ICU and elimination of the drug obtained by HD in severe cases. Conversely, MALA in patients suffering from organ failure carries a very high probability of death. The occurrence of a severe acidosis with concomitant organ failures in a diabetic patient previously treated by metformin should prompt physicians to measure plasma metformin levels and intensively manage the patient. In our study, an acute liver dysfunction assessed by the PT activity was associated with the highest risk of death. In this population, prolonged HD was required to improve metformin levels.
